- Published on
Orthopaedic Surgery - Spina Bifida
Basics
Spina bifida is a congenital condition caused by:
Incomplete closure of the posterior elements of the spine.
It is present at birth but may not be recognized until:
Later in life.
The defect may occur at:
Any spinal level
or at multiple levels, although it most commonly affects the:
Caudal spine.
When associated with a neurologic deficit, spina bifida may lead to secondary problems involving the:
Genitourinary system
and
Lower extremities.
Spina Bifida Occulta
Spina bifida occulta is a small, skin-covered defect involving the posterior arch, most often at:
L5
or
S1.
It is generally a:
Benign incidental finding
without neurologic consequences.
Patients may have a slightly increased risk of:
Spondylolisthesis.
Myelomeningocele
Myelomeningocele consists of:
Multiple absent laminae
with exposed:
Meninges
and usually abnormal neural tissue.
A neurologic deficit is commonly present at the level of the defect.
Patients have a high risk of:
Hydrocephalus
and associated:
Chiari malformation.
Lipomeningocele
A lipomeningocele is a:
Fat-containing mass
arising from the caudal spinal canal and palpable beneath the skin.
It is associated with:
Neurologic dysfunction
but generally carries no substantial risk of:
Hydrocephalus.
Motor-Level Classification
All patients with spina bifida should be classified according to their:
Motor level.
The motor level is defined as the lowest spinal level with:
Antigravity muscle strength.
The motor level should be recorded separately for:
Each limb.
Synonyms
Other terms include:
Spinal dysraphism
Neural tube defect
and
Myelomeningocele.
Prevention
Periconceptional folate supplementation may reduce the risk of:
Neural tube defects.
A commonly recommended dose is:
0.4 mg of folic acid daily
during the early months of pregnancy, particularly before conception and during the first trimester.
Epidemiology
Spina bifida affects:
Males and females equally.
Incidence
Spina bifida occulta is found in approximately:
2–3% of the general population.
The overall incidence of neural tube defects in the United States is approximately:
1 per 1,000 births.
Rates vary considerably among:
Countries and geographic regions.
The risk is increased when a:
First-degree relative
has been affected.
Prevalence
The prevalence is reported to be:
Slightly higher in White populations
and
Lower in African American populations
than in the general population.
The frequency varies substantially between:
Different countries.
Risk Factors
Recognized risk factors include:
An affected first-degree relative
and
Poor maternal or perinatal nutrition.
Genetics
Spina bifida is not inherited in a simple:
Mendelian pattern.
It is thought to follow a:
Polygenic and multifactorial pattern.
No single causative genetic abnormality has been identified in most cases.
Etiology
The underlying mechanism is failure of:
Neural tube closure
or later:
Rupture of the neural tube.
The precise cause of this failure remains:
Unknown.
Associated Conditions
Spina bifida may be associated with:
Hydrocephalus
Chiari malformation
Syringomyelia
Kyphosis
Scoliosis
Renal dysfunction
Latex allergy
Sprengel deformity
and increased risk of:
Pathologic fracture.
Diagnosis
Diagnosis is based on:
Physical examination
Neurologic assessment
and appropriate:
Prenatal or postnatal imaging.
Signs and Symptoms
Local findings depend on the type of defect.
The skin overlying the lesion may show:
A small dimple
Hair growth
Vascular markings
or other abnormal pigmentation.
Lipomeningocele
A lipomeningocele may appear as a:
Subcutaneous fatty mass.
Myelomeningocele
A myelomeningocele may present with:
Exposed meninges
and neural tissue at birth.
Spina Bifida Occulta
Spina bifida occulta usually has:
No visible physical abnormality.
Neurologic Findings
General neurologic findings may include:
Motor weakness
Calf or thigh atrophy
and a corresponding:
Sensory deficit.
Bladder Dysfunction
A:
Neurogenic bladder
is common in patients with clinically significant spina bifida.
This may lead to:
Recurrent urinary tract infections
Urinary incontinence
or progressive:
Renal damage.
Symptoms
Spina bifida itself is often:
Asymptomatic.
Back pain is not usually caused directly by the bony defect.
However, patients may develop pain or neurologic deterioration from associated:
Tethered cord
or
Spondylolisthesis.
Physical Examination
The examination should include assessment of:
Spinal alignment
Skin coverage
Motor function
Sensation
Joint motion
Contractures
Gait
and signs of associated:
Hydrocephalus or Chiari malformation.
Spinal Deformity
Evaluate for:
Scoliosis
and
Kyphosis.
These deformities may progress during growth and can interfere with:
Sitting balance
or
Mobility.
Skin Examination
The quality of the skin covering the defect is important because poor skin coverage increases the risk of later:
Skin breakdown
and
Ulceration.
Motor Examination
Record the strength of the major muscle groups.
The motor level is the lowest level demonstrating:
Contraction against resistance.
This baseline should be documented for future comparison.
Sensory Examination
Record the lowest level of preserved sensation.
The sensory level helps predict the risk of:
Pressure sores
in areas of insensate skin.
Joint Examination
Assess each joint for:
Contractures
Dislocations
Deformities
and limitations in:
Range of motion.
Gait
If the patient is ambulatory, observe:
Gait pattern
Balance
Bracing requirements
and the efficiency of:
Walking.
Hydrocephalus and Chiari Malformation
Look for clinical signs of:
Hydrocephalus
or
Chiari malformation.
These may include:
Head enlargement
Headache
Vomiting
Abnormal eye movements
Swallowing difficulty
or other:
Brainstem symptoms.
Laboratory and Prenatal Testing
For pregnancies at increased risk, prenatal evaluation may include:
Amniocentesis
with measurement of:
Alpha-fetoprotein
and
Acetylcholinesterase.
Prenatal Ultrasound
Prenatal ultrasonography can detect many neural tube defects and may identify associated:
Cranial
Spinal
and
Limb abnormalities.
Imaging
Plain Radiographs
Baseline spinal radiographs are often obtained early in infancy to identify associated congenital abnormalities such as:
Hemivertebrae
and
Congenital vertebral fusion.
These abnormalities may occur in up to:
20% of children with true spina bifida.
Pelvic Radiographs
A baseline:
Anteroposterior pelvis radiograph
may be obtained to evaluate:
Hip development
and identify associated:
Subluxation or dislocation.
MRI
MRI of the:
Neuraxis
is obtained when needed to evaluate for:
Syringomyelia
Chiari malformation
Tethered spinal cord
or other spinal cord abnormalities.
Pathological Findings
A typical myelomeningocele may contain a:
Flattened spinal cord
with:
Scarring
and
Abnormally developed neural tissue.
Hydrocephalus and Chiari Malformation
Associated findings may include:
Hydrocephalus
and
Chiari malformation
with herniation of the:
Cerebellar tonsils
through the:
Foramen magnum.
Differential Diagnosis
The differential diagnosis includes:
A defect from previous laminectomy
and
Delayed ossification of an otherwise intact posterior arch.
Treatment
Management should be:
Multidisciplinary
and individualized according to:
Motor level
Sensory function
Spinal deformity
Bladder function
Ambulatory potential
and associated:
Neurologic abnormalities.
General Measures
An experienced:
Neurologist
Neurosurgeon
Orthopaedic surgeon
and
Urologist
should evaluate the child early, ideally:
At birth.
Latex Avoidance
Patients with spina bifida should avoid:
Latex exposure
because latex allergy is common and may become severe.
Genetic Counseling
Families should be offered:
Genetic counseling
regarding recurrence risk and preventive:
Folate supplementation.
Urinary Tract Infection Prevention
Patients with recurrent urinary tract infections may require:
Long-term, low-dose prophylactic antibiotics
under the supervision of a:
Urologist.
Bladder management should be individualized and may include:
Clean intermittent catheterization.
Neurologic Monitoring
Motor strength and sensory levels should be documented throughout life to detect:
Tethered cord
or other progressive neurologic complications.
Foot Deformities
Clubfoot should initially be treated with:
Serial casting
using a method such as:
Ponseti treatment.
Other Deformities
Additional deformities may be managed with:
Stretching
Bracing
or
Surgery
depending on severity and functional impact.
Skin Protection
Families and patients should be taught to protect areas of:
Insensate skin
from:
Pressure
Heat
Friction
and
Trauma.
Daily skin inspection is important.
Support Services
Families should be connected with appropriate support organizations, such as:
The Spina Bifida Association
and other community-based resources.
Hip Subluxation
Most cases of hip subluxation do not require surgery, particularly when the condition is:
High
Bilateral
and present in a:
Nonambulatory patient.
Treatment should focus on:
Comfort
Positioning
and
Function.
Activity
Patients should be encouraged to maximize activity using the most efficient and safe method, including:
Wheelchair mobility
or
Walking with braces.
Adaptive Sports
Wheelchair sports and other adaptive activities should be offered to interested patients.
These activities can improve:
Physical fitness
Social development
and
Self-image.
Physical Therapy
Patients should receive ongoing physical therapy throughout growth to:
Maximize mobility
Monitor muscle strength
Maintain joint motion
and
Optimize the use of braces and wheelchairs.
Weight Management
A physical therapist and nutritionist may help prevent:
Excessive weight gain
which can impair:
Mobility
and increase the difficulty of transfers and self-care.
Surgery
Clubfoot Surgery
Casting is the initial treatment for clubfoot.
If residual deformity persists, surgery may be required to:
Lengthen contracted tendons
and
Realign the bones
to create a plantigrade foot that can rest:
Flat on the ground.
Other Lower-Extremity Surgery
Additional foot or leg procedures may be performed when necessary to improve:
Alignment
Brace tolerance
Standing
or
Walking.
Spine Surgery
Spinal surgery may be indicated for progressive:
Scoliosis
or
Kyphosis
that causes:
Unbalanced sitting
or significant functional impairment.
Treatment may involve:
Spinal correction and fusion
with implanted:
Growing rods
or other spinal instrumentation.
Fetal Surgery
Prenatal repair of the neural tube defect may reduce the later risk of:
Hydrocephalus
and possibly decrease the need for shunt placement.
However, fetal surgery increases the risk of:
Premature birth
and requires careful maternal-fetal evaluation.
Prognosis
With modern neonatal and multidisciplinary care, infant mortality is only:
Slightly higher than in the general population.
The prognosis is worse in patients with severe:
Spina bifida cystica
and extensive:
Central nervous system involvement.
Functional Independence
Some patients may not achieve long-term independence because of:
Neurologic impairment
Hydrocephalus
Cognitive complications
Bladder dysfunction
or severe:
Lower-extremity weakness.
Complications
Potential complications include:
Shunt failure
Tethered cord
Progressive weakness
Syringomyelia
Chiari-related symptoms
Pressure sores
Fractures
and
Renal failure.
Shunt Failure
Patients with hydrocephalus may develop:
Ventriculoperitoneal shunt failure.
This can cause:
Headache
Vomiting
Altered mental status
or new:
Neurologic deterioration.
Tethered Cord
The spinal cord may become tethered at the site of the original defect.
As the child grows, tethering may cause progressive:
Weakness
Sensory loss
Pain
or worsening:
Bladder dysfunction.
Fracture
The risk of fracture is increased in patients with a more severe:
Neurologic deficit.
Fractures may occur with minimal trauma because of:
Insensate limbs
Muscle imbalance
Osteopenia
and impaired protective responses.
Fracture Presentation
Signs of fracture may be subtle and include:
Low-grade fever
Swelling
Warmth
and little or no:
Pain.
Radiographs may show:
Exuberant callus formation.
Pressure Sores
Pressure sores may develop over:
The ischium
The foot
or
The greater trochanter.
They are especially likely in areas of:
Insensate skin.
Renal Failure
Poor bladder care and recurrent urinary tract infections may eventually lead to:
Renal impairment
or
Renal failure.
Patient Monitoring
Patients with myelomeningocele should generally be followed every:
6–12 months.
Follow-up is intended to:
Identify new problems
Monitor neurologic function
Assess spinal alignment
and
Check the fit of braces and equipment.
Neurologic Deterioration
New neurologic deficits may result from:
Shunt failure
Syringomyelia
Tethered cord
or
Chiari malformation.
Any new weakness, sensory change, pain, gait deterioration, or bladder dysfunction requires prompt evaluation.
Equipment Monitoring
Regular assessment should ensure that:
Wheelchairs
Braces
Standing devices
and other adaptive equipment remain properly fitted and functional.
Key Principle
Spina bifida is a congenital neural tube defect caused by incomplete closure of the posterior spinal elements. Its clinical severity ranges from asymptomatic spina bifida occulta to myelomeningocele with major neurologic, bladder, and lower-extremity dysfunction.
Patients should be classified by their:
Motor level
and monitored for:
Tethered cord
Hydrocephalus
Chiari malformation
Syringomyelia
Spinal deformity
Pressure sores
and
Renal complications.
Successful care requires coordinated management by:
Neurology
Neurosurgery
Orthopaedics
Urology
Physical therapy
and
Rehabilitation services.
The goals are to preserve:
Neurologic function
Skin integrity
Bladder and renal health
Mobility
and
Long-term independence.